Manufacturer: Apotex NZ Ltd manufactures Apo-Ipravent Nasal Spray.
The uses of Apo-Ipravent Nasal Spray include:
APO-IPRAVENT NASAL SPRAY 0.03% is a clear colourless solution and contain 300mcg/mL or ipratropium bromide. The solution is filled into a white opaque plastic bottle, closed with a white plastic pump and activator.
APO-IPRAVENT NASAL SPRAY is indicated for the treatment and management of perennial rhinitis, allergic rhinitis and vasomotor rhinitis when characterised by watery rhinorrhoea.
APO-IPRAVENT NASAL SPRAY is also indicated for the symptomatic relief of rhinorrhoea associated with the common cold.
Dosage and Administration
Priming of pump is required before first use.
For the treatment and management of perennial rhinitis, allergic rhinitis and vasomotor rhinitis when characterised by watery rhinorrhoea:
Adults: Two sprays up each nostril 2 - 3 times a day. Some patients may need 3 - 4 sprays up each nostril during early therapy to obtain maximum benefit during early treatment.
Children: 2 sprays up each nostril 2 times a day.
Optimal dosage varies with the response of the individual patient.
Patients with occasional episodes of watery rhinorrhoea triggered by provocating factors, e.g. temperature changes, food and exercise, should administer 2 - 4 sprays up each nostril prior to exposure.
For the symptomatic relief of rhinorrhoea associated with the common cold
0.03% strength: Initial dose: Two sprays into each nostril, followed by two further sprays five minutes after the first spray. Subsequent doses (2-3 times per day) two sprays into each nostril.
0.06% strength Two sprays per nostril 3 or 4 times a day
Treatment in the common cold has only been studied up to four days. Efficacy and safety of treatment beyond four days have not been established, although there has been no evidence of adverse safety effects with longer treatment in perennial rhinitis patients.